Alan Alfieri

3.2k total citations
66 papers, 2.6k citations indexed

About

Alan Alfieri is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alan Alfieri has authored 66 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alan Alfieri's work include Cancer, Hypoxia, and Metabolism (11 papers), Virus-based gene therapy research (9 papers) and Cancer Research and Treatments (7 papers). Alan Alfieri is often cited by papers focused on Cancer, Hypoxia, and Metabolism (11 papers), Virus-based gene therapy research (9 papers) and Cancer Research and Treatments (7 papers). Alan Alfieri collaborates with scholars based in United States, Italy and France. Alan Alfieri's co-authors include Chandan Guha, Jae Ho Kim, Sang Hie Kim, Eric Hahn, Bhadrasain Vikram, Charles W. Young, Jason A. Koutcher, Laibin Liu, Subhrajit Saha and Kathryn E. Tanaka and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Alan Alfieri

66 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Alfieri United States 28 816 595 584 523 361 66 2.6k
James A. Radosevich United States 31 932 1.1× 290 0.5× 518 0.9× 860 1.6× 558 1.5× 137 3.0k
Helen B. Stone United States 17 433 0.5× 980 1.6× 496 0.8× 643 1.2× 291 0.8× 33 2.1k
Douglas K. Trask United States 23 1.3k 1.6× 304 0.5× 694 1.2× 238 0.5× 285 0.8× 51 2.6k
Yoshihiro Minamiya Japan 33 1.2k 1.5× 229 0.4× 984 1.7× 1.3k 2.5× 948 2.6× 237 3.7k
Xiaodong Zhu China 25 610 0.7× 306 0.5× 692 1.2× 520 1.0× 451 1.2× 164 2.2k
Romaine E. Saxton United States 30 1.1k 1.4× 897 1.5× 422 0.7× 570 1.1× 207 0.6× 114 2.6k
Risto Johansson Finland 28 1.3k 1.6× 154 0.3× 798 1.4× 335 0.6× 395 1.1× 73 2.8k
Dietmar Berger Germany 28 622 0.8× 140 0.2× 582 1.0× 592 1.1× 395 1.1× 66 2.8k
Jean‐Louis Merlin France 30 974 1.2× 223 0.4× 963 1.6× 828 1.6× 246 0.7× 154 2.7k
Jitsuo Usuda Japan 34 537 0.7× 309 0.5× 491 0.8× 2.1k 4.1× 515 1.4× 131 3.1k

Countries citing papers authored by Alan Alfieri

Since Specialization
Citations

This map shows the geographic impact of Alan Alfieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Alfieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Alfieri more than expected).

Fields of papers citing papers by Alan Alfieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Alfieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Alfieri. The network helps show where Alan Alfieri may publish in the future.

Co-authorship network of co-authors of Alan Alfieri

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Alfieri. A scholar is included among the top collaborators of Alan Alfieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Alfieri. Alan Alfieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Friedman, Adam, Kenny Ye, Alicia Rodriguez‐Gabin, et al.. (2018). Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin. SHILAP Revista de lepidopterología. 1(3). 173–182. 8 indexed citations
2.
Kulkarni, S., Antonius Koller, Kartik Mani, et al.. (2016). Identifying Urinary and Serum Exosome Biomarkers for Radiation Exposure Using a Data Dependent Acquisition and SWATH-MS Combined Workflow. International Journal of Radiation Oncology*Biology*Physics. 96(3). 566–577. 28 indexed citations
3.
Basu, Indranil, Seema Gupta, Alan Alfieri, et al.. (2014). Rigosertib Is a More Effective Radiosensitizer Than Cisplatin in Concurrent Chemoradiation Treatment of Cervical Carcinoma, In Vitro and In Vivo. International Journal of Radiation Oncology*Biology*Physics. 88(5). 1180–1187. 26 indexed citations
4.
5.
Saha, Subhrajit, Payel Bhanja, Rafi Kabarriti, et al.. (2011). Bone Marrow Stromal Cell Transplantation Mitigates Radiation-Induced Gastrointestinal Syndrome in Mice. PLoS ONE. 6(9). e24072–e24072. 109 indexed citations
6.
Nguyen, Nam P., Cheryl Frank, Candace C. Moltz, et al.. (2009). Aspiration Risk and Postoperative Radiation for Head and Neck Cancer. Cancer Investigation. 27(1). 47–51. 3 indexed citations
7.
Zeman, Richard J., et al.. (2008). STEREOTACTIC RADIOSURGERY IMPROVES LOCOMOTOR RECOVERY AFTER SPINAL CORD INJURY IN RATS. Neurosurgery. 63(5). 981–988. 11 indexed citations
8.
9.
Xu, Su, Kristen L. Zakian, Howard T. Thaler, et al.. (2001). Effects of Motexafin gadolinium on tumor metabolism and radiation sensitivity. International Journal of Radiation Oncology*Biology*Physics. 49(5). 1381–1390. 55 indexed citations
10.
Alfieri, Alan, et al.. (1998). Multimodality Therapy: Radiation and Continuous Concomitant Cis-platinum and PKC Inhibition in a Cervical Carcinoma Model. Cancer Investigation. 16(7). 462–470. 4 indexed citations
11.
Street, James C., Alan Alfieri, & Jason A. Koutcher. (1997). Quantitation of metabolic and radiobiological effects of 6-aminonicotinamide in RIF-1 tumor cells in vitro.. PubMed. 57(18). 3956–62. 28 indexed citations
12.
Street, James C., Umar Mahmood, Douglas Ballon, Alan Alfieri, & Jason A. Koutcher. (1996). 13C and 31P NMR Investigation of Effect of 6-Aminonicotinamide on Metabolism of RIF-1 Tumor Cells in Vitro. Journal of Biological Chemistry. 271(8). 4113–4119. 33 indexed citations
13.
Koutcher, Jason A., Alan Alfieri, M. Devitt, et al.. (1992). Quantitative changes in tumor metabolism, partial pressure of oxygen, and radiobiological oxygenation status postradiation.. PubMed. 52(17). 4620–7. 58 indexed citations
14.
Kim, Jae Ho, et al.. (1990). Low dose rate radiotherapy for transplantable gliosarcoma in the rat brain. Journal of Neuro-Oncology. 9(1). 9–15. 8 indexed citations
15.
Kim, Jae Ho, Alan Alfieri, Sang Hie Kim, & Seung Soo Hong. (1990). Radiosensitization of two murine fibrosarcomas with 6-thioguanine. International Journal of Radiation Oncology*Biology*Physics. 18(3). 583–586. 4 indexed citations
16.
Hong, Seong Su, et al.. (1989). Effects of intratumoral injection of I‐125 lododeoxyuridine on ehrlich ascites carcinoma. Journal of Surgical Oncology. 42(3). 187–191. 1 indexed citations
17.
Kim, Jae Ho, et al.. (1989). Potentiation of radiation effects on multicellular tumor spheroids (mts) of hela cells by lonidamine. International Journal of Radiation Oncology*Biology*Physics. 16(5). 1277–1280. 13 indexed citations
18.
Brooks, Marjory B., Robert E. Matus, Connie E. Leifer, Alan Alfieri, & Amiya K. Patnaik. (1988). Chemotherapy Versus Chemotherapy Plus Radiotherapy in the Treatment of Tonsillar Squamous Cell Carcinoma in the Dog. Journal of Veterinary Internal Medicine. 2(4). 206–211. 28 indexed citations
19.
Kim, Sang Hie, et al.. (1984). Lonidamine: A Hyperthermic Sensitizer of HeLa Cells in Culture and of the Meth-A Tumor in vivo. Oncology. 41(1). 30–35. 42 indexed citations
20.
Alfieri, Alan & Eric Hahn. (1978). An in situ method for estimating cell survival in a solid tumor.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(9). 3006–11. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James A. Radosevich Breakdown of academic impact, for papers by Helen B. Stone Breakdown of academic impact, for papers by Douglas K. Trask Breakdown of academic impact, for papers by Yoshihiro Minamiya Breakdown of academic impact, for papers by Xiaodong Zhu Breakdown of academic impact, for papers by Romaine E. Saxton Breakdown of academic impact, for papers by Risto Johansson Breakdown of academic impact, for papers by Dietmar Berger Breakdown of academic impact, for papers by Jean‐Louis Merlin Breakdown of academic impact, for papers by Jitsuo Usuda
Rankless by CCL
2026